0 results for 'Cantor Colburn'
Conn. IP Firm Helps ESPN Star Patent A Really Cool Cooler
If you've ever gone tailgating, either at a sports event or an outdoor concert, then you probably have witnessed or experienced what some could call an unintentional workout.
Conn. IP Firm Expansion Includes Former Pratt & Whitney Counsel
The Hartford-based intellectual property firm of Cantor Colburn has added two new attorneys, including a former in-house counsel for Connecticut aircraft engine maker Pratt & Whitney.
Colt Targets O'Melveny As Debt Forces Bankruptcy Filing
Long after the Colt .45 tamed the American West, Samuel Colt's namesake company is waving the white flag in a showdown with its creditors.
Conn. IP Firm Expansion Includes Former Pratt & Whitney Counsel
The Hartford-based intellectual property firm of Cantor Colburn has added two new attorneys, including a former in-house counsel for Connecticut aircraft engine maker Pratt & Whitney.
Colt Targets O'Melveny As Debt Forces Bankruptcy Filing
Long after the Colt .45 tamed the American West, Samuel Colt's namesake company is waving the white flag in a showdown with its creditors.
Fuzzy Jury Instructions Affected 'Blurred Lines' Case
Singer-songwriters Robin Thicke, Clifford "T.I." Harris and Pharrell Williams' song "Blurred Lines" was released in 2013 and quickly climbed the charts to become the longest-running No 1 single of 2013. Unfortunately for Thicke and Williams, their success hit a sour note when the estate of legendary rhythm and blues artist Marvin Gaye received a $7.4 million jury verdict for copyright infringement.
Will Biosimilar Applicants Opt Out of Patent Dance?
On March 6, the federal Food and Drug Administration licensed the first-ever U.S. biosimilar drug, Sandoz's Zarxio, a version of Amgen's Neupogen (filgrastim). Less than two weeks later, the U.S. District Court for the Northern District of California denied Amgen's motion for a preliminary injunction against Sandoz's Zarxio launch, removing the final barrier to consumers being able to obtain the drug.
A New Era in Intellectual Property Law
On Sept. 16, 2012, new procedures became available under the AIA for third parties to challenge the validity of someone else's patent at the U.S. Patent and Trademark Office. This article focuses on two of these new post-grant proceedings: inter partes review (IPR) and post-grant review (PGR).
Successful Bar Candidates-July 2014 Bar Examination
Notice to the bar.Patent Litigation Shows No Signs of Going Out of Style
The number of suits keeps rising, with Fish & Richardson topping our law firm rankings for the most cases handled.TRENDING STORIES
More from ALM
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Vaishali Rao, Hinshaw & Culbertson Partner 1 minute read
Resources
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now